Jackson Square Capital LLC Purchases 7,760 Shares of Waters Corporation $WAT

Key Points

• Jackson Square Capital purchased 7,760 Waters shares worth approximately $3.41 million during the third quarter. Institutional investors collectively own 94.01% of the company.
• Waters reported quarterly EPS of $3.05, exceeding estimates of $3.01, while revenue reached $1.65 billion and rose 113.3% year over year. The company issued FY 2026 EPS guidance of $14.45–$14.65.
• Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and an average price target of $443.79; shares recently traded at $434.75.

Jackson Square Capital LLC bought a new position in shares of Waters Corporation (NYSE:WAT - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 7,760 shares of the medical instruments supplier's stock, valued at approximately $3,410,000.

Other institutional investors also recently bought and sold shares of the company. BDF Gestion purchased a new position in Waters in the third quarter valued at $2,160,000. V Square Quantitative Management LLC boosted its stake in shares of Waters by 3.3% during the 3rd quarter. V Square Quantitative Management LLC now owns 2,623 shares of the medical instruments supplier's stock worth $1,153,000 after acquiring an additional 85 shares in the last quarter. QRG Capital Management Inc. boosted its stake in shares of Waters by 10.5% during the 2nd quarter. QRG Capital Management Inc. now owns 3,273 shares of the medical instruments supplier's stock worth $1,227,000 after acquiring an additional 310 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its position in shares of Waters by 29.3% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 1,131 shares of the medical instruments supplier's stock valued at $424,000 after acquiring an additional 256 shares during the period. Finally, State Street Corp grew its position in shares of Waters by 0.5% during the 2nd quarter. State Street Corp now owns 4,382,008 shares of the medical instruments supplier's stock valued at $1,643,428,000 after acquiring an additional 19,998 shares during the period. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Waters news, Director Christopher Kuebler sold 3,626 shares of the company's stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the sale, the director directly owned 17,808 shares in the company, valued at $7,086,515.52. This represents a 16.92% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.31% of the company's stock.

Waters Price Performance

Shares of WAT traded down $2.20 during trading hours on Monday, hitting $434.75. 181,855 shares of the stock were exchanged, compared to its average volume of 959,684. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. Waters Corporation has a 12-month low of $282.77 and a 12-month high of $454.54. The company has a market cap of $42.71 billion, a price-to-earnings ratio of 108.46, a price-to-earnings-growth ratio of 2.54 and a beta of 1.15. The stock's 50-day moving average price is $420.83 and its two-hundred day moving average price is $376.76.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, beating the consensus estimate of $3.01 by $0.04. Waters had a return on equity of 11.27% and a net margin of 3.58%. The firm had revenue of $1.65 billion during the quarter, compared to analysts' expectations of $1.62 billion. During the same quarter last year, the firm earned $2.95 earnings per share. The business's revenue for the quarter was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Research analysts expect that Waters Corporation will post 14.56 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $400.00 target price on shares of Waters in a research report on Wednesday, August 5th. The Goldman Sachs Group increased their price objective on shares of Waters from $465.00 to $515.00 and gave the company a "buy" rating in a report on Monday, September 21st. Citigroup lifted their target price on shares of Waters from $425.00 to $470.00 and gave the company a "buy" rating in a research report on Monday, August 10th. UBS Group raised shares of Waters from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $375.00 to $490.00 in a research note on Wednesday, September 9th. Finally, Evercore restated an "outperform" rating and set a $420.00 price target on shares of Waters in a research report on Wednesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $443.79.

About Waters

Waters Corporation NYSE: WAT develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company's product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.